SPOTLIGHT: Critics challenge direct-to-consumer TV ads for stent


Over the last several months, consumers have been viewing a 60-second television ad for Johnson & Johnson's Cypher stent which, of course, plays up its potential benefits. Now, two critics of the ad have published an article in The New England Journal of Medicine arguing that the ad does far too little to warn consumers about the potential dangers of receiving a stent. The authors, Dr. William E. Boden of the State University of New York at Buffalo's medical school, and Dr. George Diamond of Cedars-Sinai Medical Center, question whether such high-risk procedures should be advertised directly to the public at all. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.